Correction: Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis buffer.

Autor: Erster O, Shkedi O, Benedek G, Zilber E, Varkovitzky I, Shirazi R, Shorka DO, Cohen Y, Bar T, Yechieli R, Oikawa MT, Venkert D, Linial M, Oiknine-Djian E, Mandelboim M, Livneh Z, Shenhav-Saltzman G, Mendelson E, Wolf D, Szwarcwort-Cohen M, Mor O, Lewis Y, Zeevi D

Publikováno v: PloS one [PLoS One] 2024 Nov 14; Vol. 19 (11), pp. e0314219. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2024).

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation.

Autor: Oved K; Canopy Immuno-Therapeutics and MeMed Diagnostics, Tirat Carmel, Israel., Olmer L; The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel., Shemer-Avni Y; Laboratory of Clinical Virology Clalit HMO and Soroka Medical Center, Beer-Sheva, Israel., Wolf T; Laboratory Division, Maccabi HMO, Rehovot, Israel., Supino-Rosin L; Laboratory Division, Maccabi HMO, Rehovot, Israel., Prajgrod G; Laboratory Division, Meuhedet HMO, Rehovot, Israel., Shenhar Y; Laboratory Division, Leumit HMO, Or-Yehuda, Israel., Payorsky I; Laboratory Division, Leumit HMO, Or-Yehuda, Israel., Cohen Y; Directorate of Defence Research and Development, Ministry of Defense, Tel Aviv, Israel., Kohn Y; Directorate of Defence Research and Development, Ministry of Defense, Tel Aviv, Israel., Indenbaum V; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel., Lazar R; Laboratory Division, Maccabi HMO, Rehovot, Israel., Geylis V; Laboratory Division, Maccabi HMO, Rehovot, Israel., Oikawa MT; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel., Shinar E; Magen David National Blood Services, Tel Hashomer, Israel., Stoyanov E; Magen David National Blood Services, Tel Hashomer, Israel., Keinan-Boker L; Israel Center for Disease Control, Ministry of Health, Chaim Sheba Medical center, Tel-Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Israel., Bassal R; Israel Center for Disease Control, Ministry of Health, Chaim Sheba Medical center, Tel-Hashomer, Israel., Reicher S; Ministry of Health, Jerusalem, Israel., Yishai R; Ministry of Health, Jerusalem, Israel.; Department of Laboratories, Public Health Services, Ministry of Health, Israel., Bar-Chaim A; Asaaf Harofeh Medical Center, Be'er Ya'akov, Israel., Doolman R; Sheba Medical Center. Tel Hashomer, Israel., Reiter Y; The Technion Institute of Technology, Haifa, Israel., Mendelson E; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Israel., Livneh Z; Dept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Freedman LS; The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel., Lustig Y; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2020 Dec; Vol. 29, pp. 100651. Date of Electronic Publication: 2020 Nov 19.

The role of immunoglobulin prophylaxis for prevention of cytomegalovirus infection in pediatric hematopoietic stem cell transplantation recipients.

Autor: Goldstein G; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Rutenberg TF; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Mendelovich SL; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Hutt D; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Oikawa MT; Central Virology Laboratory, Israel Ministry of Health, Tel Hashomer, Israel., Toren A; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Bielorai B; Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation, The Edmond and Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2017 Jul; Vol. 64 (7). Date of Electronic Publication: 2017 Jan 14.